To use all functions of this page, please activate cookies in your browser.
My watch list
my.bionity.com
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
244 Newest Publications in nature clinical practice neurology
rss |
You can refine your search further. Select from the filter options on the left to narrow down your results. |
Cerebral small vessel disease: from a focal to a global perspective
25-May-2018 | Annemieke Telgte; Esther M. C. Leijsen; Kim Wiegertjes; Catharina J. M. Klijn; Anil M. Tuladhar; Frank-Erik Leeuw, Nature Clinical Practice Neurology, 2018
Cerebral small vessel disease (SVD) is commonly observed on neuroimaging among elderly individuals and is recognized as a major vascular contributor to dementia, cognitive decline, gait impairment, mood disturbance and stroke. However, clinical symptoms are often highly inconsistent in nature and ...
Selective neuronal loss could limit penumbral rescue after stroke
24-May-2018 | Heather Wood, Nature Clinical Practice Neurology, 2018
Selective neuronal loss could limit penumbral rescue after stroke Selective neuronal loss could limit penumbral rescue after stroke, Published online: 24 May 2018; doi:10.1038/s41582-018-0015-x Selective neuronal loss could limit penumbral rescue after stroke
Tau seeding starts early in the entorhinal cortex
24-May-2018 | Charlotte Ridler, Nature Clinical Practice Neurology, 2018
Tau seeding starts early in the entorhinal cortex Tau seeding starts early in the entorhinal cortex, Published online: 24 May 2018; doi:10.1038/s41582-018-0016-9 Tau seeding starts early in the entorhinal cortex
New biomarker predicts disability in MS
23-May-2018 | Charlotte Ridler, Nature Clinical Practice Neurology, 2018
New biomarker predicts disability in MS New biomarker predicts disability in MS, Published online: 23 May 2018; doi:10.1038/s41582-018-0017-8 New biomarker predicts disability in MS
Deep brain stimulation boosts motor connectivity
23-May-2018 | Charlotte Ridler, Nature Clinical Practice Neurology, 2018
Deep brain stimulation boosts motor connectivity Deep brain stimulation boosts motor connectivity, Published online: 23 May 2018; doi:10.1038/s41582-018-0018-7 Deep brain stimulation boosts motor connectivity
Genotype–phenotype links in frontotemporal lobar degeneration
18-May-2018 | Sara Van Mossevelde; Sebastiaan Engelborghs; Julie van der Zee; Christine Van Broeckhoven, Nature Clinical Practice Neurology, 2018
Frontotemporal lobar degeneration (FTLD) represents a group of neurodegenerative brain diseases with highly heterogeneous clinical, neuropathological and genetic characteristics. This high degree of heterogeneity results from the presence of several different underlying molecular disease ...
A stocked toolbox for understanding the role of astrocytes in disease
16-May-2018 | Akshata Almad; Nicholas J. Maragakis, Nature Clinical Practice Neurology, 2018
Our understanding of astrocytes and their role in neurological diseases has increased considerably over the past two decades as the diverse roles of these cells have become recognized. Our evolving understanding of these cells suggests that they are more than support cells for neurons and that ...
Neuroimaging model predicts time of symptom onset in sporadic AD
15-May-2018 | Charlotte Ridler, Nature Clinical Practice Neurology, 2018
Neuroimaging model predicts time of symptom onset in sporadic AD Neuroimaging model predicts time of symptom onset in sporadic AD, Published online: 15 May 2018; doi:10.1038/s41582-018-0011-1 Neuroimaging model predicts time of symptom onset in sporadic AD
Stars of neurology meet at AAN 2018
15-May-2018 | Heather Wood, Nature Clinical Practice Neurology, 2018
Stars of neurology meet at AAN 2018 Stars of neurology meet at AAN 2018, Published online: 15 May 2018; doi:10.1038/s41582-018-0012-0 Stars of neurology meet at AAN 2018
Amyloid-β — a reflection of risk or a preclinical marker?
30-Apr-2018 | Clifford R. Jack; Prashanthi Vemuri, Nature Clinical Practice Neurology, 2018
Amyloid-β — a reflection of risk or a preclinical marker? Amyloid-β — a reflection of risk or a preclinical marker?, Published online: 30 April 2018; doi:10.1038/s41582-018-0008-9 In a recent study, individuals with brain amyloid-β accumulation but no cognitive impairment were classified as ...
